Word

INCYCLIX BIO

Status

Registered

Status Code

700

Status Date

Tuesday, October 3, 2023

Serial Number

97300706

Registration Number

7184421

Registration Date

Tuesday, October 3, 2023

Mark Type

4000

Filing Date

Tuesday, March 8, 2022

Published for Opposition

Tuesday, January 24, 2023

Trademark Owner History

Incyclix Bio, LLC - Original Registrant

Classifications

42 Pharmaceutical research and development services in the field of oncology; Research and development of pharmaceuticals and therapeutics in the field oncology; Pharmaceutical product development services in the field of cyclin-dependent kinases (CDKs) for the treatment of advanced and resistant cancers; Scientific research for medical purposes in the area of cancerous diseases; Research and development of cyclin-dependent kinase (CDK) based pharmaceuticals for the treatment of cancer and oncological conditions; Research and development in the field of cyclin-dependent kinases (CDKs) for the treatment of advanced and resistant cancers; Providing information about medical research in the field of cancerous diseases

"BIO"

Trademark Events

Oct 3, 2023

Notice Of Registration Confirmation Emailed

Oct 3, 2023

Registered-Principal Register

Aug 31, 2023

Notice Of Acceptance Of Statement Of Use E-Mailed

Aug 30, 2023

Allowed Principal Register - Sou Accepted

Aug 10, 2023

Notice Of Approval Of Extension Request E-Mailed

Aug 9, 2023

Statement Of Use Processing Complete

Aug 1, 2023

Use Amendment Filed

Aug 9, 2023

Sou Extension 1 Granted

Aug 1, 2023

Sou Extension 1 Filed

Aug 9, 2023

Case Assigned To Intent To Use Paralegal

Aug 1, 2023

Sou Teas Extension Received

Aug 1, 2023

Teas Statement Of Use Received

Mar 21, 2023

Noa E-Mailed - Sou Required From Applicant

Jan 24, 2023

Official Gazette Publication Confirmation E-Mailed

Jan 24, 2023

Published For Opposition

Jan 4, 2023

Notification Of Notice Of Publication E-Mailed

Dec 20, 2022

Approved For Pub - Principal Register

Dec 20, 2022

Examiner's Amendment Entered

Dec 20, 2022

Notification Of Examiners Amendment E-Mailed

Dec 20, 2022

Examiners Amendment E-Mailed

Dec 20, 2022

Examiners Amendment -Written

Dec 19, 2022

Assigned To Examiner

Mar 12, 2022

New Application Office Supplied Data Entered

Mar 11, 2022

New Application Entered